Published on 24 May 2021 on Simply Wall St. via Yahoo Finance
Every investor in Odonate Therapeutics, Inc. (NASDAQ:ODT) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. We also tend to see lower insider ownership in companies that were previously publicly owned.
With a market capitalization of US$147m, Odonate Therapeutics is a small cap stock, so it might not be well known by many institutional investors. In the chart below, we can see that institutional investors have bought into the company. Let's delve deeper into each type of owner, to discover more about Odonate Therapeutics.
See our latest analysis for Odonate Therapeutics